Biomedical Engineering Reference
In-Depth Information
61. Park, K., et al.,
Target specific tumor treatment by VEGF siRNA
complexed with reducible polyethyleneimine-hyaluronic acid conjugate.
Biomaterials, 2010.
31
(19): p. 5258-5265.
62. Canal, F., et al.,
Relevance of folic acid/polymer ratio in targeted PEG-
epirubicin conjugates.
J Control Release, 2010.
146
(3): p. 388-399.
63. Pinhassi, R.I., et al.,
Arabinogalactan-folic acid-drug conjugate for
targeted delivery and target-activated release of anticancer drugs to
folate receptor-overexpressing cells.
Biomacromolecules.
11
(1): p.
294-303.
64. Pasut, G., et al.,
Antitumoral activity of PEG-gemcitabine prodrugs
targeted by folic acid.
J Control Release, 2008.
127
(3): p. 239-248.
65. Yang, X., et al., Tumor-targeting, pH-responsive, and stable unimolecular
micelles as drug nanocarriers for targeted cancer therapy
.
Bioconjug
Chem
.
66. Bae, Y., N. Nishiyama, and K. Kataoka,
In vivo antitumor activity of the
folate-conjugated pH-sensitive polymeric micelle selectively releasing
adriamycin in the intracellular acidic compartments.
Bioconjug Chem,
2007.
18
(4): p. 1131-1139.
67. Thomas, T.P., et al.,
Targeting and inhibition of cell growth by an
engineered dendritic nanodevice.
J Med Chem, 2005.
48
(11): p. 3729-
3735.
68. Daniels, T.R., et al.,
The transferrin receptor part II: targeted delivery
of therapeutic agents into cancer cells.
Clin Immunol, 2006.
121
(2): p.
159-176.
69. Gomme, P.T., K.B. McCann, and J. Bertolini,
Transferrin: structure,
function and potential therapeutic actions.
Drug Discov Today, 2005.
10
(4): p. 267-273.
70. Tsukagoshi, S.,
A new LH-RH agonist for treatment of prostate cancer,
3-month controlled-release formulation of goserelin acetate (Zoladex
LA 10.8 mg depot) — outline of pre-clinical and clinical studies.
Gan To
Kagaku Ryoho, 2002.
29
(9): p. 1675-1687.
71. Dharap, S.S., et al.,
Molecular targeting of drug delivery systems to
ovarian cancer by BH3 and LHRH peptides.
J Control Release, 2003.
91
(1-2): p. 61-73.
72. Khandare, J.J., et al.,
Novel polymeric prodrug with multivalent
components for cancer therapy.
J Pharmacol Exp Ther, 2006.
317
(3): p.
929-937.
73. Heyns, C.F., et al.,
Comparative efficacy of triptorelin pamoate and
leuprolide acetate in men with advanced prostate cancer.
BJU Int, 2003.
92
(3): p. 226-231.
Search WWH ::
Custom Search